CAPRICORN

Effect of Carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial - The Lancet – 2001

Brief Summary:

In patients with acute MI and evidence of LV systolic dysfunction (EF < 40%), treatment with carvedilol is associated with decreased mortality.

Reference:
http://www.ncbi.nlm.nih.gov/pubmed/11356434

Comments